Logo image of CBLL

CERIBELL INC (CBLL) Stock Price, Quote, News and Overview

NASDAQ:CBLL - Nasdaq - US15678C1027 - Common Stock - Currency: USD

16.18  -0.14 (-0.86%)

After market: 16.18 0 (0%)

CBLL Quote, Performance and Key Statistics

CERIBELL INC

NASDAQ:CBLL (5/5/2025, 8:00:02 PM)

After market: 16.18 0 (0%)

16.18

-0.14 (-0.86%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap580.38M
Shares35.87M
Float28.05M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-08 2025-05-08/amc
IPO10-11 2024-10-11


CBLL short term performance overview.The bars show the price performance of CBLL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

CBLL long term performance overview.The bars show the price performance of CBLL in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of CBLL is 16.18 USD. In the past month the price decreased by -12.26%.

CERIBELL INC / CBLL Daily stock chart

CBLL Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.74 229.97B
ISRG INTUITIVE SURGICAL INC 69.61 190.61B
BSX BOSTON SCIENTIFIC CORP 38.61 154.18B
SYK STRYKER CORP 30.44 145.56B
MDT MEDTRONIC PLC 15.63 107.03B
BDX BECTON DICKINSON AND CO 11.85 47.95B
EW EDWARDS LIFESCIENCES CORP 28.89 44.16B
IDXX IDEXX LABORATORIES INC 41.67 38.50B
RMD RESMED INC 26.5 35.29B
GEHC GE HEALTHCARE TECHNOLOGY 15.08 31.76B
DXCM DEXCOM INC 48.65 31.47B
PHG KONINKLIJKE PHILIPS NVR- NY 16.33 24.10B

About CBLL

Company Profile

Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 281 full-time employees. The company went IPO on 2024-10-11. The firm has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

Company Info

CERIBELL INC

360 N. Pastoria Avenue

Sunnyvale CALIFORNIA US

Employees: 281

CBLL Company Website

Phone: 18004360826

CERIBELL INC / CBLL FAQ

What is the stock price of CERIBELL INC today?

The current stock price of CBLL is 16.18 USD. The price decreased by -0.86% in the last trading session.


What is the ticker symbol for CERIBELL INC stock?

The exchange symbol of CERIBELL INC is CBLL and it is listed on the Nasdaq exchange.


On which exchange is CBLL stock listed?

CBLL stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for CERIBELL INC stock?

12 analysts have analysed CBLL and the average price target is 33.66 USD. This implies a price increase of 108.03% is expected in the next year compared to the current price of 16.18. Check the CERIBELL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CERIBELL INC worth?

CERIBELL INC (CBLL) has a market capitalization of 580.38M USD. This makes CBLL a Small Cap stock.


How many employees does CERIBELL INC have?

CERIBELL INC (CBLL) currently has 281 employees.


What are the support and resistance levels for CERIBELL INC (CBLL) stock?

CERIBELL INC (CBLL) has a support level at 14.48 and a resistance level at 16.32. Check the full technical report for a detailed analysis of CBLL support and resistance levels.


Is CERIBELL INC (CBLL) expected to grow?

The Revenue of CERIBELL INC (CBLL) is expected to grow by 30.35% in the next year. Check the estimates tab for more information on the CBLL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CERIBELL INC (CBLL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CERIBELL INC (CBLL) stock pay dividends?

CBLL does not pay a dividend.


When does CERIBELL INC (CBLL) report earnings?

CERIBELL INC (CBLL) will report earnings on 2025-05-08, after the market close.


What is the Price/Earnings (PE) ratio of CERIBELL INC (CBLL)?

CERIBELL INC (CBLL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.13).


What is the Short Interest ratio of CERIBELL INC (CBLL) stock?

The outstanding short interest for CERIBELL INC (CBLL) is 4.52% of its float. Check the ownership tab for more information on the CBLL short interest.


CBLL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CBLL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CBLL. CBLL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CBLL Financial Highlights

Over the last trailing twelve months CBLL reported a non-GAAP Earnings per Share(EPS) of -1.13. The EPS decreased by -30.29% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -17.95%
ROE -21.16%
Debt/Equity 0.1
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-30.29%
Revenue 1Y (TTM)44.71%

CBLL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 87% to CBLL. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 25.99% and a revenue growth 30.35% for CBLL


Ownership
Inst Owners70.12%
Ins Owners9.52%
Short Float %4.52%
Short Ratio4.22
Analysts
Analysts86.67
Price Target33.66 (108.03%)
EPS Next Y25.99%
Revenue Next Year30.35%